Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by wyndeweston Feb 15, 2017 5:41pm
517 Views
Post# 25851660

RE:RE:Shorts

RE:RE:ShortsBarcode, you obviously understand the market, healthcare sector and PLI in particular based on your recent posts and past posts for that matter.  I always enjoy your take backed by technicals.  Do you have an opinion as to why the short position has increased to 57mm at this point and time and NOT decreased. It is sooo contrary to what I am thinking re. Prometic's bright future.  The only thing I can think of is they are betting Prometic won't deliver in February as Fred promised....???
Bullboard Posts